- Published at
- by gurufocus.com
positive
positive
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix's ADC technology
PR NewswireAMSTERDAM, BASEL, Switzerland and INGELHEIM, Germany, Jan. 9, 2025
AMSTERDAM, BASEL, Switzerland and INGELHEIM, Germany, Jan. 9, 2025 /PRNewswir